{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:26:20Z","timestamp":1793294780398,"version":"4.5.0"},"reference-count":42,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2016,10,16]],"date-time":"2016-10-16T00:00:00Z","timestamp":1476576000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Department of Clinical Medicine, University of Bergen and Helse Vest, Haukeland University Hospital, Bergen, Norway"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurogastroenterology Motil"],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      A diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (\n                      <jats:styled-content style=\"fixed-case\">FODMAP<\/jats:styled-content>\n                      s) is increasingly recommended for patients with irritable bowel syndrome (\n                      <jats:styled-content style=\"fixed-case\">IBS<\/jats:styled-content>\n                      ). We aimed to investigate the effects of a blinded low\u2010\n                      <jats:styled-content style=\"fixed-case\">FODMAP<\/jats:styled-content>\n                      vs high\u2010fructo\u2010oligosaccharides (\n                      <jats:styled-content style=\"fixed-case\">FOS<\/jats:styled-content>\n                      ) diet on symptoms, immune activation, gut microbiota composition, and short\u2010chain fatty acids (\n                      <jats:styled-content style=\"fixed-case\">SCFA<\/jats:styled-content>\n                      s).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Twenty patients with diarrhea\u2010predominant or mixed\n                      <jats:styled-content style=\"fixed-case\">IBS<\/jats:styled-content>\n                      were instructed to follow a low\u2010\n                      <jats:styled-content style=\"fixed-case\">FODMAP<\/jats:styled-content>\n                      diet (\n                      <jats:styled-content style=\"fixed-case\">LFD<\/jats:styled-content>\n                      ) throughout a 9\u2010week study period. After 3\u00a0weeks, they were randomized and double\u2010blindly assigned to receive a supplement of either\n                      <jats:styled-content style=\"fixed-case\">FOS<\/jats:styled-content>\n                      (\n                      <jats:styled-content style=\"fixed-case\">FODMAP<\/jats:styled-content>\n                      ) or maltodextrin (placebo) for the next 10\u00a0days, followed by a 3\u2010week washout period before crossover. Irritable bowel syndrome severity scoring system (\n                      <jats:styled-content style=\"fixed-case\">IBS<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">SSS<\/jats:styled-content>\n                      ) was used to evaluate symptoms. Cytokines (interleukin [\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      ]\u20106,\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u20108, and tumor necrosis factor alpha) were analyzed in blood samples, and gut microbiota composition (16S\n                      <jats:styled-content style=\"fixed-case\">rRNA<\/jats:styled-content>\n                      ) and\n                      <jats:styled-content style=\"fixed-case\">SCFA<\/jats:styled-content>\n                      s were analyzed in fecal samples.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Results<\/jats:title>\n                    <jats:p>\n                      Irritable bowel syndrome symptoms consistently improved after 3\u00a0weeks of\n                      <jats:styled-content style=\"fixed-case\">LFD<\/jats:styled-content>\n                      , and significantly more participants reported symptom relief in response to placebo (80%) than\n                      <jats:styled-content style=\"fixed-case\">FOS<\/jats:styled-content>\n                      (30%). Serum levels of proinflammatory\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u20106 and\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u20108, as well as levels of fecal bacteria (Actinobacteria, Bifidobacterium, and\n                      <jats:italic>Faecalibacterium prausnitzii<\/jats:italic>\n                      ), total\n                      <jats:styled-content style=\"fixed-case\">SCFA<\/jats:styled-content>\n                      s, and n\u2010butyric acid, decreased significantly on the\n                      <jats:styled-content style=\"fixed-case\">LFD<\/jats:styled-content>\n                      as compared to baseline. Ten days of\n                      <jats:styled-content style=\"fixed-case\">FOS<\/jats:styled-content>\n                      supplementation increased the level of these bacteria, whereas levels of cytokines and\n                      <jats:styled-content style=\"fixed-case\">SCFA<\/jats:styled-content>\n                      s remained unchanged.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Inferences<\/jats:title>\n                    <jats:p>\n                      Our findings support the efficacy of a\n                      <jats:styled-content style=\"fixed-case\">LFD<\/jats:styled-content>\n                      in alleviating\n                      <jats:styled-content style=\"fixed-case\">IBS<\/jats:styled-content>\n                      symptoms, and show changes in inflammatory cytokines, microbiota profile, and\n                      <jats:styled-content style=\"fixed-case\">SCFA<\/jats:styled-content>\n                      s, which may have consequences for gut health.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/nmo.12969","type":"journal-article","created":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T00:53:32Z","timestamp":1476665612000},"source":"Crossref","is-referenced-by-count":179,"title":["Effects of varying dietary content of fermentable short\u2010chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome"],"prefix":"10.1111","volume":"29","author":[{"given":"T. N.","family":"Hustoft","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine University of Bergen  Bergen Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Hausken","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine University of Bergen  Bergen Norway"},{"name":"Section of Gastroenterology Department of Medicine Haukeland University Hospital  Bergen Norway"},{"name":"National Centre of Functional Gastrointestinal Disorders Haukeland University Hospital  Bergen Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. O.","family":"Ystad","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine University of Bergen  Bergen Norway"},{"name":"National Centre of Functional Gastrointestinal Disorders Haukeland University Hospital  Bergen Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Valeur","sequence":"additional","affiliation":[{"name":"Unger\u2010Vetlesen's Institute Lovisenberg Diaconal Hospital  Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Brokstad","sequence":"additional","affiliation":[{"name":"Department of Clinical Science University of Bergen  Bergen Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. G.","family":"Hatlebakk","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine University of Bergen  Bergen Norway"},{"name":"Section of Gastroenterology Department of Medicine Haukeland University Hospital  Bergen Norway"},{"name":"National Centre of Functional Gastrointestinal Disorders Haukeland University Hospital  Bergen Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. A.","family":"Lied","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine University of Bergen  Bergen Norway"},{"name":"Section of Gastroenterology Department of Medicine Haukeland University Hospital  Bergen Norway"},{"name":"National Centre of Functional Gastrointestinal Disorders Haukeland University Hospital  Bergen Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,10,16]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.0954"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i34.12144"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/490183"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-015-0922-1"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X11436241"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2010.06370.x"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2011.06650.x"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.96"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.386"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-015-0022-3"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.07.054"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-277X.2011.01162.x"},{"key":"e_1_2_9_14_1","first-page":"338","article-title":"Study design considerations for irritable bowel syndrome clinical trials","volume":"27","author":"Miller LE","year":"2014","journal-title":"Ann Gastroenterol"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.3945\/jn.112.159285"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.142318000.x"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.02.058"},{"issue":"7","key":"e_1_2_9_18_1","doi-asserted-by":"crossref","first-page":"1412S","DOI":"10.1093\/jn\/129.7.1412S","article-title":"Inulin and oligofructose: safe intakes and legal status","volume":"129","author":"Coussement PA","year":"1999","journal-title":"J Nutr"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-015-0922-1"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13236"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(77)90312-6"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.1984.12005738"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2009.06149.x"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.04.051"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.167270"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.5056\/jnm.2011.17.3.252"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl\u20102015\u2010311339"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114510003363"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0029665116000021"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-307264"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114516000908"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.03.082"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2009.01324.x"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2011.01775.x"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v17.i12.1519"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.12358"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2011.11.019"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.7869\/tg.2012.66"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2015.12.013"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.159"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-013-2926-0"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.033"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu3060637"}],"container-title":["Neurogastroenterology &amp; Motility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fnmo.12969","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fnmo.12969","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/nmo.12969","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T02:40:05Z","timestamp":1696214405000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/nmo.12969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,16]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.1111\/nmo.12969"],"URL":"https:\/\/doi.org\/10.1111\/nmo.12969","archive":["Portico"],"relation":{},"ISSN":["1350-1925","1365-2982"],"issn-type":[{"value":"1350-1925","type":"print"},{"value":"1365-2982","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,16]]},"article-number":"e12969"}}